pain and fever

Manufacturer: Meijer Distribution Inc
Effective date: 2024-09-27
Label type: HUMAN OTC DRUG LABEL
Version: 7
Source: full-release
Hydrated at: 2026-06-01 00:22:46

Label at a glance#

Productpain and fever

Active ingredientACETAMINOPHEN

Label structure9 sections

Indications and uses

temporarily: • reduces fever • relieves minor aches and pains due to: • the common cold • flu • headache • sore throat • toothache

Dosage and administration

• this product does not contain directions or complete warnings for adult use • do not give more than directed (see overdose warning) • shake well before using • mL = milliliter • find right dose on chart. If possible, use weight to dose; otherwise, use age. • push air out of syringe. Insert syringe tip into bottle opening. • flip bottle upside down. Pull yellow part of syringe to the first dose line and then push...

Storage and handling

• store at 20-25°C (68-77°F) • do not use if printed neckband is broken or missing

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-800-719-9260

Label contents#

Full prescribing information#

Active ingredient (in each 5 mL)

OTC - ACTIVE INGREDIENT SECTION

Acetaminophen 160 mg

Purpose

OTC - PURPOSE SECTION

Pain reliever/fever reducer

Uses

INDICATIONS & USAGE SECTION

temporarily:

reduces fever
relieves minor aches and pains due to:
the common cold
flu
headache
sore throat
toothache

Warnings

WARNINGS SECTION

Liver warning: This product contains acetaminophen. Severe liver damage may occur if your child takes

more than 5 doses in 24 hours, which is the maximum daily amount
with other drugs containing acetaminophen

Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include:

skin reddening
blisters
rash

If a skin reaction occurs, stop use and seek medical help right away.

Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.

Do not use

OTC - DO NOT USE SECTION

with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
if your child has ever had an allergic reaction to this product or any of its ingredients

Ask a doctor before use if your child has

OTC - ASK DOCTOR SECTION

liver disease

Ask a doctor or pharmacist before use if your child is

OTC - ASK DOCTOR/PHARMACIST SECTION

taking the blood thinning drug warfarin

When using this product

OVERDOSAGE SECTION

do not exceed recommended dose (see overdose warning)

Stop use and ask a doctor if

OTC - STOP USE SECTION

pain gets worse or lasts more than 5 days
fever gets worse or lasts more than 3 days
new symptoms occur
redness or swelling is present. These could be signs of a serious condition.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical even if you do not notice any signs or symptoms.

Directions

DOSAGE & ADMINISTRATION SECTION

this product does not contain directions or complete warnings for adult use
do not give more than directed (see overdose warning)
shake well before using
mL = milliliter
find right dose on chart. If possible, use weight to dose; otherwise, use age.
push air out of syringe. Insert syringe tip into bottle opening.
flip bottle upside down. Pull yellow part of syringe to the first dose line and then push product back into bottle.
pull yellow part of syringe until it reaches and stays at the correct dose
dispense liquid slowly into child’s mouth, toward inner cheek
repeat dose every 4 hours while symptoms last
do not give more than 5 times in 24 hours
replace cap tightly to maintain child resistance

Dosing Chart

Weight (lb)	Age (yr)	Dose (mL)*
under 24	under 2 years	ask a doctor
24-35	2-3 years	5 mL

*or as directed by a doctor

Attention: use only enclosed syringe specifically designed for use with this product. Do not use any other dosing device.

Other information

STORAGE AND HANDLING SECTION

store at 20-25°C (68-77°F)
do not use if printed neckband is broken or missing

Inactive ingredients

INACTIVE INGREDIENT SECTION

anhydrous citric acid, calcium sulfate, carrageenan, flavor, glycerin, hydroxyethyl cellulose, microcrystalline cellulose and carboxymethylcellulose sodium, propylene glycol, purified water, sodium benzoate, sorbitol solution, sucralose, tribasic sodium phosphate

Questions or comments?

OTC - QUESTIONS SECTION

1-800-719-9260

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

meijer_®

INFANTS’ | ages 2-3 years

pain & fever

acetaminophen 160 mg per 5 mL oral suspension

pain reliever | fever reducer

COMPARE TO INFANTS’ TYLENOL^®

ACTIVE INGREDIENT

DYE FREE

FAST, EFFECTIVE, RELIEF OF INFANTS’ PAIN AND FEVER

GRAPE FLAVOR

Aspirin Free

Ibuprofen Free

Alcohol Free

Paraben Free

No High Fructose Corn Syrup

Use only with enclosed syringe. See side panel for more information.

2 FL OZ (59 mL)

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
307668	acetaminophen 160 MG in 5 mL Oral Suspension	PSN	7
307668	acetaminophen 32 MG/ML Oral Suspension	SCD	7
307668	acetaminophen 160 MG per 5 ML Oral Suspension	SY	7
307668	acetaminophen 320 MG per 10 ML Oral Suspension	SY	7
307668	acetaminophen 650 MG per 20.3 ML Oral Suspension	SY	7
307668	acetaminophen 80 MG per 2.5 ML Oral Suspension	SY	7
307668	APAP 32 MG/ML Oral Suspension	SY	7

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
41250-766-10	pain and fever	30 mL in 1 BOTTLE	SUSPENSION	30	7
41250-766-10	pain and fever	1 in 1 CARTON	SUSPENSION	1	7
41250-766-16	pain and fever	1 in 1 CARTON	SUSPENSION	1	7
41250-766-16	pain and fever	59 mL in 1 BOTTLE	SUSPENSION	59	7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
41250-766	PAIN AND FEVER (ACETAMINOPHEN) SUSPENSION [MEIJER DISTRIBUTION INC]	7	Current NDC, Legacy NDC, 4 package rows	20241006_eef2fef5-34b3-4ac2-94cb-5bd6b4c5ab1c.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ACETAMINOPHEN	ACTIVE INGREDIENT	362O9ITL9D	3
ACETAMINOPHEN	ACTIVE MOIETY	362O9ITL9D	3
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	3
CALCIUM SULFATE	INACTIVE INGREDIENT	WAT0DDB505	3
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	3
CARRAGEENAN	INACTIVE INGREDIENT	5C69YCD2YJ	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	3
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	3
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	3
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	3
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	3
SODIUM PHOSPHATE, TRIBASIC	INACTIVE INGREDIENT	A752Q30A6X	3
SORBITOL	INACTIVE INGREDIENT	506T60A25R	3
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

pain and fever
Acetaminophen
ANHYDROUS CITRIC ACID
CALCIUM SULFATE, UNSPECIFIED FORM
CARRAGEENAN
GLYCERIN
HYDROXYETHYL CELLULOSE, UNSPECIFIED
MICROCRYSTALLINE CELLULOSE
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED
PROPYLENE GLYCOL
WATER
SODIUM BENZOATE
SORBITOL SOLUTION
SUCRALOSE
SODIUM PHOSPHATE, TRIBASIC

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
41250-766	41250-766-16, 41250-766-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ACETAMINOPHEN	362O9ITL9D	ACTIB
ANHYDROUS CITRIC ACID	XF417D3PSL	IACT
CALCIUM SULFATE, UNSPECIFIED FORM	WAT0DDB505	IACT
CARRAGEENAN	5C69YCD2YJ	IACT
GLYCERIN	PDC6A3C0OX	IACT
HYDROXYETHYL CELLULOSE, UNSPECIFIED	T4V6TWG28D	IACT
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED	K679OBS311	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
WATER	059QF0KO0R	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
SORBITOL SOLUTION	8KW3E207O2	IACT
SUCRALOSE	96K6UQ3ZD4	IACT
SODIUM PHOSPHATE, TRIBASIC	A752Q30A6X	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 54 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
CARRAGEENAN	CARRAGEENAN	5C69YCD2YJ	SUSPENSION / ORAL	6 mg/5ml		Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION / ORAL		64 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SUSPENSION / ORAL		26208 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SUSPENSION / ORAL		26208 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET / ORAL		2734 mg	Exact identifier — unii+route 18 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET, DELAYED RELEASE / ORAL	127 mg		Exact identifier — unii+route 18 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	SUSPENSION / ORAL		1080 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
SODIUM PHOSPHATE, TRIBASIC	SODIUM PHOSPHATE, TRIBASIC	A752Q30A6X	POWDER, FOR SUSPENSION / ORAL		650 mg	Exact identifier — unii+route 6 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION / ORAL		320 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / ORAL		27120 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	SUSPENSION / ORAL		1600 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
SODIUM PHOSPHATE, TRIBASIC	SODIUM PHOSPHATE, TRIBASIC	A752Q30A6X	GRANULE / ORAL		1 mg	Exact identifier — unii+route 6 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	CAPSULE, EXTENDED RELEASE / ORAL	1.66 mg		Exact identifier — unii+route 18 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	SUSPENSION / ORAL		1080 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	CAPSULE, EXTENDED RELEASE / ORAL	1.66 mg		Exact identifier — unii+route 18 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET, DELAYED RELEASE / ORAL	127 mg		Exact identifier — unii+route 18 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	CAPSULE / ORAL	141.5 mg		Exact identifier — unii+route 18 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SUSPENSION / ORAL		26208 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / ORAL		27120 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION / ORAL		64 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET / ORAL		2734 mg	Exact identifier — unii+route 18 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / ORAL		27120 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET, COATED / ORAL	170 mg		Exact identifier — unii+route 18 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	SUSPENSION / ORAL		400 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	SUSPENSION / ORAL		1080 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET, EXTENDED RELEASE / ORAL	235 mg		Exact identifier — unii+route 18 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	SUSPENSION / ORAL		1600 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
SODIUM PHOSPHATE, TRIBASIC	SODIUM PHOSPHATE, TRIBASIC	A752Q30A6X	POWDER, FOR SUSPENSION / ORAL		650 mg	Exact identifier — unii+route 6 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION / ORAL		320 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET, EXTENDED RELEASE / ORAL	235 mg		Exact identifier — unii+route 18 equally ranked IID candidates
SODIUM PHOSPHATE, TRIBASIC	SODIUM PHOSPHATE, TRIBASIC	A752Q30A6X	GRANULE / ORAL		1 mg	Exact identifier — unii+route 6 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	CAPSULE, EXTENDED RELEASE / ORAL	1.66 mg		Exact identifier — unii+route 18 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	SUSPENSION / ORAL		45000 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET, EXTENDED RELEASE / ORAL	235 mg		Exact identifier — unii+route 18 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SUSPENSION / ORAL		383 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	CAPSULE / ORAL	141.5 mg		Exact identifier — unii+route 18 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION / ORAL		320 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	SUSPENSION / ORAL		400 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	CAPSULE / ORAL	141.5 mg		Exact identifier — unii+route 18 equally ranked IID candidates
SODIUM PHOSPHATE, TRIBASIC	SODIUM PHOSPHATE, TRIBASIC	A752Q30A6X	POWDER, FOR SUSPENSION / ORAL		650 mg	Exact identifier — unii+route 6 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET, COATED / ORAL	170 mg		Exact identifier — unii+route 18 equally ranked IID candidates
CARRAGEENAN	CARRAGEENAN	5C69YCD2YJ	SUSPENSION / ORAL	6 mg/5ml		Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET, COATED / ORAL	170 mg		Exact identifier — unii+route 18 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION / ORAL		64 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET, DELAYED RELEASE / ORAL	127 mg		Exact identifier — unii+route 18 equally ranked IID candidates
SODIUM PHOSPHATE, TRIBASIC	SODIUM PHOSPHATE, TRIBASIC	A752Q30A6X	GRANULE / ORAL		1 mg	Exact identifier — unii+route 6 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	SUSPENSION / ORAL		400 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	SUSPENSION / ORAL		1600 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	SUSPENSION / ORAL		45000 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SUSPENSION / ORAL		383 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SUSPENSION / ORAL		383 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CALCIUM SULFATE	CALCIUM SULFATE	WAT0DDB505	TABLET / ORAL		2734 mg	Exact identifier — unii+route 18 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	SUSPENSION / ORAL		45000 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CARRAGEENAN	CARRAGEENAN	5C69YCD2YJ	SUSPENSION / ORAL	6 mg/5ml		Exact identifier — unii+route+dosage form 3 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
pain and fever	ACETAMINOPHEN	Meijer Distribution Inc	eef2fef5-34b3-4ac2-94cb-5bd6b4c5ab1c	2024-09-27	Warnings	Exact identifier ndc (package): 41250-766-10 ndc (package): 41250-766-16 ndc (product): 41250-766 ndc11 (package): 41250076616 ndc11 (package): 41250076610 spl id: e52420c5-19fd-4666-9319-daf87090e6cc spl set id: eef2fef5-34b3-4ac2-94cb-5bd6b4c5ab1c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.